404 related articles for article (PubMed ID: 16392767)
21. Influence of age and hypertension on the association between small artery compliance and coronary artery disease.
Takeuchi K; Zhang B; Ideishi M; Urata H; Noda K; Tashiro T; Kimura M; Saku K
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1188-91. PubMed ID: 15607628
[TBL] [Abstract][Full Text] [Related]
22. Hypertension management in outpatient visits by diabetic patients.
Aparasu RR; Aparasu A
Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038
[TBL] [Abstract][Full Text] [Related]
23. Arterial elasticity among normotensive subjects and treated and untreated hypertensive subjects: influence of race.
Prisant LM; Resnick LM; Hollenberg SM; Jupin D
Ethn Dis; 2002; 12(1):63-8. PubMed ID: 11913610
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II receptor antagonists supplementation is associated with arterial stiffness: insight from a retrospective study in 116 peritoneal dialysis patients.
Huang WH; Hsu CW; Chen YC; Hung CC; Huang JY; Lin JL; Yang CW
Ren Fail; 2007; 29(7):843-8. PubMed ID: 17994453
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
Imaizumi S; Miura S; Nishikawa H; Iwata A; Zhang B; Kawamura A; Tsuchiya Y; Kumagai K; Matsuo K; Saku K
Hypertens Res; 2006 Mar; 29(3):135-41. PubMed ID: 16755148
[TBL] [Abstract][Full Text] [Related]
26. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
Kudoh T; Nagawaga T; Nakagawa I
Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
[TBL] [Abstract][Full Text] [Related]
27. Improvement of blood pressure control in hypertensive patients with renal diseases.
Ohta Y; Tsuruya K; Fujii K; Tokumoto M; Kanai H; Matsumura K; Tsuchihashi T; Hirakata H; Iida M
Hypertens Res; 2007 Apr; 30(4):295-300. PubMed ID: 17541207
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety of high-dose angiotensin receptor blocker therapy in hypertensive patients with chronic kidney disease.
Weinberg AJ; Zappe DH; Ramadugu R; Weinberg MS
J Hypertens Suppl; 2006 Mar; 24(1):S95-9. PubMed ID: 16601581
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures.
Greenberg J
Am J Hypertens; 2005 Aug; 18(8):1033-9. PubMed ID: 16109316
[TBL] [Abstract][Full Text] [Related]
30. Relationship between birthweight and arterial elasticity in childhood.
Rondó PH; Lemos JO; Pereira JA; Oliveira JM; Innocente LR
Clin Sci (Lond); 2008 Nov; 115(10):317-26. PubMed ID: 18393941
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
Barski L; Porath A; Novack V; Jotkowitz A
Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
[TBL] [Abstract][Full Text] [Related]
32. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome: treatment of hypertensive patients.
Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
[TBL] [Abstract][Full Text] [Related]
34. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
35. Effect of long-term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2-year follow-up study.
Shargorodsky M; Michaelova K; Boaz M; Gavish D; Zimlichman R
Diabet Med; 2007 Nov; 24(11):1254-60. PubMed ID: 17725634
[TBL] [Abstract][Full Text] [Related]
36. Different patterns of one-year evolution of microalbuminuria in hypertensive patients treated with different inhibitors of the renin-angiotensin system.
Cotter J; Oliveira P; Cunha P; Polónia J
Rev Port Cardiol; 2008 Nov; 27(11):1395-404. PubMed ID: 19227807
[TBL] [Abstract][Full Text] [Related]
37. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin receptor blockade in the challenging era of systolic hypertension.
Stergiou GS
J Hum Hypertens; 2004 Dec; 18(12):837-47. PubMed ID: 15318161
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?
Volpe M; Ruilope LM; McInnes GT; Waeber B; Weber MA
J Hum Hypertens; 2005 May; 19(5):331-9. PubMed ID: 15744333
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
